L516-0203 Screening compound: N-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide

L516-0203 Screening compound: N-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide
L516-0203 Screening compound: N-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L516-0203
N-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L516-0203

Molecular Formula

C26H29N3O3S2 (C26 H29 N3 O3 S2)

Compound Name

N-[(2-phenyl-1,3-thiazol-4-yl)methyl]-1-(5,6,7,8-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide

IUPAC name

N-[(2-phenyl-13-thiazol-4-yl)methyl]-1-(5678-tetrahydronaphthalene-2-sulfonyl)piperidine-4-carboxamide

SMILES

O=C(C(CC1)CCN1S(c1cc(CCCC2)c2cc1)(=O)=O)NCc1csc(-c2ccccc2)n1

InChI

InChI=1S/C26H29N3O3S2/c30-25(27-17-23-18-33-26(28-23)21-7-2-1-3-8-21)20-12-14-29(15-13-20)34(31,32)24-11-10-19-6-4-5-9-22(19)16-24/h1-3,7-8,10-11,16,18,20H,4-6,9,12-15,17H2,(H,27,30)

InChI Key

WCDBSFKFZIYVCH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15129115

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.67

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.030

Distribution Coefficient, logD

5.030

Water Solubility, LogSw

-4.91

Polar Surface Area

66.513

Acid Dissociation Constant (pKa)

13.30

Base Dissociation Constant (pKb)

-0.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.50

L516-0203 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PLpro Library (6343 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L516-0203 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L516-0203?
Check Price and Availability of L516-0203, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L516-0203 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L516-0203
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L516-0203
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L516-0203 available by request